Landscapes / Companies
Genfit not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 5 in all
Trials
2 active
10 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Aug 2027Phase 2 trial completes | |||
| Next date | Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Acute Decompensation of Liver Cirrhosis, Established Acute-on-Chronic Liver Failure | ||||
| Open drug page | |||||
— |
Genoscience Pharma |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | ||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Cholangiocarcinoma | ||||
| Open drug page | |||||
About
- No active trial
- elafibranor, G1090N, VS-01
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021